Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity
- Conditions
- HepatitisTuberculosis
- Registration Number
- NCT00564642
- Lead Sponsor
- National Research Institute of Tuberculosis and Lung Disease, Iran
- Brief Summary
Tuberculosis is one of the major health problems in developing countries. Isoniazid, rifampin and pyrazinamide, the first line drugs used for tuberculosis chemotherapy, are associated with hepatotoxicity. The rate of hepatotoxicity has been reported to be much higher in developing countries compared to that in advanced countries with a similar dose schedule. Oxidative stress has proposed as one of the mechanisms responsible for anti-tuberculosis drugs induced hepatic injury. The oxidative stress is closely associated with decrease of glutathione levels. In the present study N acetylcysteine, a precursor of glutathione, was investigated for hepatoprotective effect against anti-tuberculosis drugs induced liver injury.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- Two sputum specimens positives for tubercle bacilli on direct smear microscopy
- No previous anti-TB chemotherapy higher than two weeks
- Aged 60 years and over
- Agreement to participate in the study
- Alcohol consumption
- Viral disease (Hepatitis,...)
- Abnormal pretreatment LFT level
- Chronic disease (liver and kidney disease, asthma,...)
- Additional hepatotoxic drug use
- HIV positive
- Liver TB
- Patient in a moribund state
- Hemoptysis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Hepatotoxicity Two weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
National Research Institute of Tuberculosis and Lung Disease (NRITLD)
🇮🇷Tehran, Iran, Islamic Republic of